fincash logo SOLUTIONS

Fincash » Search » Dr Reddy's Laboratories Ltd

Dr Reddy s Laboratories Ltd

Updated on October 19, 2020

Stock/Share Code - DRREDDY

Dr Reddys Laboratories is a leading India-based pharmaceutical company headquartered and having its registered offi ce in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical more

Below is the details of DRREDDY Dr Reddy s Laboratories Ltd

Market Cap₹70,789 Cr.
Current Price ₹5,018.25 as on 23 Oct 20
52 Week High / Low Price₹4,758.6 / ₹2,495.05
Face Value₹5
Stock P/E21.20
Book Value₹913.77
Dividend Yield0.59 %
ROCE18.57 %
ROE21.04 %
Sales Growth (3yrs)6.83 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 32.90%
Cons: Stock is trading at 4.66 times its book value The company has delivered a poor growth of 3.43% over past five years. Promoter holding is low: 26.80% Tax rate seems low Company has a low return on equity of 12.53% for last 3 years.

Dr Reddy s Laboratories Ltd Price Chart

Dr Reddy s Laboratories Ltd Price Chart

Dr Reddy s Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹171.25 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs 21.23 ₹70,902.77 Cr. 0.59 ₹950.2 Cr. 73.36 29.33 3244.40 18.57
3. Cipla ₹757.55 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹782.8 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹417.2 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹52.65 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹424.3 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Alkem Lab ₹2,601.1 23.87 ₹32,553.96 Cr. 0.92 ₹422.01 Cr. 127.54 8.33 2003.49 18.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Dr Reddy s Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -2,2542,5232,4922,6182,6312,7322,6452,5093,4463,0442,8523,244
YOY Sales Growth %-14.20%-1.77%5.60%25.26%16.71%8.27%6.13%-4.16%30.98%11.43%7.81%29.33%
Expenses -1,9411,9882,1662,0432,0662,0452,2092,0782,2852,2882,3312,316
Material Cost %29.35%25.64%30.08%26.25%26.84%28.50%32.74%30.47%27.36%30.19%33.23%27.60%
Employee Cost %20.07%18.89%18.59%17.84%19.12%17.27%18.52%19.91%14.59%16.79%18.12%16.80%
Operating Profit3145363265755656874374311,161756521929
OPM %14%21%13%22%21%25%17%17%34%25%18%29%
Other Income404873357593734717769127645
Profit before tax1403721964014335702966931,0216184441,362
Tax %28%20%10%18%20%30%32%21%-34%16%-13%30%
Net Profit1012971773293463992035481,365522503950
EPS in Rs6.0717.9010.6519.8220.8624.0812.2233.0682.3631.4730.2457.31

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -4,1594,5125,2436,7408,3709,72810,01110,2929,7209,35910,62611,85012,586
Sales Growth %23.59%8.50%16.19%28.55%24.20%16.22%2.91%2.81%-5.56%-3.71%13.53%11.53%
Expenses -3,3093,4014,0525,1926,3856,9667,6208,2277,9498,0298,3268,9679,220
Material Cost %26.77%27.23%30.27%28.81%30.70%25.60%28.17%25.79%26.52%28.11%28.59%30.16%
Manufacturing Cost %14.41%12.75%7.93%7.97%6.95%10.98%11.44%11.97%13.23%14.47%10.21%9.32%
Employee Cost %9.92%11.44%13.40%12.93%13.67%14.68%14.97%16.53%18.63%19.76%18.26%17.22%
Other Cost %28.47%23.94%25.69%27.33%24.96%20.36%21.54%25.65%23.40%23.46%21.30%18.97%
Operating Profit8501,1111,1901,5481,9862,7622,3912,0651,7711,3302,3002,8833,366
OPM %20%25%23%23%24%28%24%20%18%14%22%24%27%
Other Income10121211982142152223325566204238730918
Profit before tax7301,0851,0521,2591,7532,4542,0601,6771,5446971,7012,7763,444
Tax %23%22%15%28%28%21%18%18%10%19%25%-6%
Net Profit5618468939121,2661,9331,6791,3741,3845671,2772,9383,340
EPS in Rs32.2548.2550.9851.5771.98113.5694.4880.5683.4834.1576.95176.76201.38
Dividend Payout %19%22%21%26%20%16%20%25%24%59%26%14%

Compounded Sales Growth

  • 10 Years:: 10.14%
  • 5 Years:: 3.43%
  • 3 Years:: 6.83%
  • TTM:: 19.68%

Compounded Profit Growth

  • 10 Years:: 13.29%
  • 5 Years:: 12.53%
  • 3 Years:: 28.00%
  • TTM:: 123.17%

Return on Equity

  • 10 Years:: 11.85%
  • 5 Years:: 0.27%
  • 3 Years:: 24.29%
  • 1 Year:: 66.49%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -848485858585858583838383
Equity Capital848485858585858583838383
Other Liabilities -1,2741,7641,7072,0872,1062,5132,6962,4222,4912,7042,4452,726
Trade Payables7801,1946047337688427167197791,0611,0321,068
Advance from Customers0001840002324195249
Other liability items4945701,1031,1701,3381,6711,9801,6801,6891,6241,3621,609
Total Liabilities7,1748,2429,26310,34111,98914,50816,45617,58516,44717,10016,24819,476
Fixed Assets -1,2111,3161,6911,8972,3872,7483,2494,4384,8424,7174,6834,434
Gross Block2,1572,4263,0253,5084,2094,9005,8167,5808,6759,2249,77410,216
Accumulated Depreciation9461,1101,3341,6111,8222,1512,5663,1423,8334,5065,0915,782
Other Assets -3,8483,6264,5645,3486,8008,3778,8567,4557,9638,0727,2319,145
Trade receivables1,4201,0601,7701,9442,9644,5624,7123,8904,4054,2043,7184,639
Cash Equivalents384368668499196659012026712111339
Loans n Advances1,3311,3217766801,0271,0461,0001,4281,3961,5211,1861,987
Other asset items-23-21888550364513519236286369198289
Total Assets7,1748,2429,26310,34111,98914,50816,45617,58516,44717,10016,24819,476

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -4861,2532461,4032899061,7862,7471,0161,5392,7621,839
Profit from operations9921,4411,3282,1402,4383,4732,6562,7652,1931,6612,6593,458
Loans Advances5-107-151000000000
Other WC items000249-420-74186-12156-3156689
Working capital changes-33533-871-344-1,774-2,024-391379-85451342-1,142
Direct taxes-176-220-211-394-376-543-479-397-323-174-239-477
Exceptional CF items400000000000
Cash from Investing Activity --744-1,117-609-425-524-874-2,031-1,9191,430-1,180-546-1,689
Fixed assets purchased-545-383-696-601-580-872-962-1,084-985-798-653-474
Fixed assets sold3193022781212886
Investments purchased-1,373-2,696-1,162-1,370-1,186-3,581-3,595-6,532-4,850-6,062-7,727-12,273
Investments sold1,6352,1101,2601,1781,2633,1072,6106,4206,9535,6287,47910,919
Interest received5657475893897310862348259
Dividends received55603110213200040
Loans to subsidiaries-448-223-700420131-2-1000
Other investing items-76-64310-160355-306-852-70618434
Cash from Financing Activity -106-15261-19515228189-693-2,582-304-2,223-224
Proceeds from shares023100000000
Redemption of debentures00000-508000000
Proceeds from borrowings6377302,1032,2063,0264,4402,7372,57601650463
Repayment of borrowings-440-749-1,222-2,116-2,516-3,523-2,122-2,787-614-0-1,705-180
Interest paid fin-18-12-4-63-88-83-69-75-64-71-64-53
Dividends paid-74-123-814-222-271-298-357-407-335-399-400-391
Financial liabilities00000000000-16
Other financing items00-5-00000-1,5690-54-47
Net Cash Flow-152-16-302783-8460-56135-13554-8-74

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %13%18%15%17%20%23%16%12%11%5%12%19%
Debtor Days12586123105129171172138165164128143
Inventory Turnover1.751.631.771.772.001.771.881.711.641.601.721.84

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Dr Reddy s Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.